| # | Name | Description | Category | Type | Source | Website |
|---|
| # | Opportunity | Type | Region / Country | Amount | Deadline | Source |
|---|---|---|---|---|---|---|
| 40876 | Sustainable and Competitive Cell Production Techniques for Lithium-ion And Sodium-ion Batteries (BATT4EU Partnership) Expected Outcome:Proposals are expected to contribute to all following points:Significantly enhanced competitiveness, resilience,... | Research Funding Cash Grant | Europe | Expected EU contribution: 18,900,000 EUR - 18,900,000 EUR | Open Mar 31, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:Proposals are expected to contribute to all following points:Significantly enhanced competitiveness, resilience, and sustainability of the European battery cell manufacturing industry, achieving measurable reductions in capital expenditure (CAPEX), operational expenditure (OPEX), energy consumption, and environmental footprint compared to state-of-the-art processes.Demonstrated advanced manufacturing processes and equipment that substantially decrease battery production costs and improve overall production efficiency and battery quality.Established flexible and modular pilot production lines capable of efficiently transitioning between various battery chemistries and compositions, with demonstrated reduction in cross-contamination and effective management of sensitive materials. Scope:Proposals are expected to target the development and demonstration of innovative, next-... |
||||||
| 40877 | Production technologies for solar photovoltaics beyond the state-of-the-art (EUPI-PV Partnership) Expected Outcome:The REPowerEU plan and the EU Solar Energy Strategy introduced targets for the deployment of solar PV amounting t... | Research Funding Cash Grant | Europe | Expected EU contribution: 12,000,000 EUR - 12,000,000 EUR | Open Mar 31, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:The REPowerEU plan and the EU Solar Energy Strategy introduced targets for the deployment of solar PV amounting to 600 GWac by 2030. Complying with these targets will be crucial for the European Union to reach its climate targets and free itself from import dependency on fossil fuels and the costs this imposes on Europe’s competitiveness in terms of high energy prices. The Solar Strategy also introduces a target, which has been enshrined into the Net-Zero Industry Act, to re-consolidate the European solar manufacturing sector and scale up European manufacturing capacity across the entire value chain to at least 40% of the EU’s annual deployment needs, or 30 GW of annual capacity by 2030. Innovation is particularly important in the solar PV sector, which is characterised by a short technology cycle, where new technologies become mainstream in only a few years. Novel techn... |
||||||
| 40878 | Improvement of Adaptability, Flexibility and Efficiency of Existing Recycling Processes (BATT4EU Partnership) Expected Outcome:Proposals are expected to contribute to all following points:Improving cost and recovery efficiency of existing s... | Research Funding Cash Grant | Europe | Expected EU contribution: 9,400,000 EUR - 9,400,000 EUR | Open Mar 31, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:Proposals are expected to contribute to all following points:Improving cost and recovery efficiency of existing scaled recycling technologiesDemonstrated technological solutions capable of efficiently recycling diverse feedstocks, including production scrap, and mixed lithium-ion battery chemistriesImproved European competitiveness by reducing EU dependence on imported raw materials through improved recycling processesDemonstrable compliance with the targets and requirements set by the EU Batteries Regulation, including recycling efficiency and material recovery rates. Scope:Proposals under this topic are expected to specifically address innovation actions that enhance the adaptability, flexibility, and operational efficiency of existing battery recycling processes.Projects are expected to explicitly target improvements for processing mixed input streams, particularly pr... |
||||||
| 40879 | Co-funding Strategic Energy Technology (SET) Plan renewable fuel value chains at EU, national, regional, and local level Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Advance in the realisation o... | Research Funding Cash Grant | Europe | Expected EU contribution: 30,000,000 EUR - 30,000,000 EUR | Open Mar 31, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:Project results are expected to contribute to all of the following expected outcomes:Advance in the realisation of the Strategic Energy Technology (SET) Plan Action of Renewable fuels and Bioenergy (for the fuels part) is supported, overcoming fragmentation by mobilizing resources and establishing across EU interregional value chains of renewable fuel technologies and by better alignment of public and private R&I priorities and of funding mechanisms.All sector stakeholders benefit from establishment of renewable fuels value chains at EU, national, regional, and local level overcoming fragmentation across Europe.Different stakeholders (e.g., EU, SET Plan countries, regions, communities, etc) benefit from their engagement in the co-creation of a very flexible R&I Programme in renewable fuels.Researchers, industry, and public authorities have access to increased knowledge a... |
||||||
| 40880 | Advancements in Direct Air Capture Expected Outcome:Project results are expected to contribute to the following outcome:Accelerating the commercial availability of D... | Research Funding Cash Grant | Europe | Expected EU contribution: 8,000,000 EUR - 8,000,000 EUR | Open Mar 31, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:Project results are expected to contribute to the following outcome:Accelerating the commercial availability of Direct Air Capture technologies. Scope:Projects are expected to aim at scaling up existing technical solutions to at least the level of pilot demonstration in relevant environments (TRL 7 or higher).Projects are expected to demonstrate:Improving the cost efficiency of the capture and regeneration process, including Balance of Plant;Improving material performance and process designs (e.g. capture/desorption capacity and kinetics, durability, long-term stability in air);Potential for manufacturing and scale-up (recycling and reuse of materials);Flexible operation under intermittent or surplus renewable energy supply. Depending on the technology, other important issues to address are:Reducing energy use for sorbent/solvent regeneration;Alternative materials for -... |
||||||
| 40881 | Large scale operational validation and upscaling of state-of-the-art (Generative) AI tools and models powering a next generation digital energy system Expected Outcome:Project results are expected to contribute to all the following expected outcomes:Advanced, secure frugal (energy... | Research Funding Cash Grant | Europe | Expected EU contribution: 10,000,000 EUR - 10,000,000 EUR | Open Mar 31, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:Project results are expected to contribute to all the following expected outcomes:Advanced, secure frugal (energy-, resource-, data- and cost-efficient, sustainable) AI tools for real-time grid operations (including protection), market operations (if relevant) and consumer empowerment in distributed energy systems.A demonstrated AI development environment integrated with the upgraded digital spine of the energy system and energy-saving consumer applications.Scaled-up capabilities for learning at edge nodes and federated systems using agent-based architectures.A governance framework and operating model for the Gen(AI)-powered digital spine. Scope:Building up on previous actions in Horizon Europe (e.g. the digital spine of the energy system in cluster 5 as well as cloud and edge continuum and AI data processing activities in cluster 4) and Digital Europe (Common Reference... |
||||||
| 40882 | Concentrated solar thermal systems for decarbonising industrial processes Expected Outcome:Renewable heating can be directly used to efficiently decarbonise industrial processes. Concentrated solar therma... | Research Funding Cash Grant | Europe | Expected EU contribution: 6,000,000 EUR - 6,000,000 EUR | Open Mar 31, 2027 Open | EU Funding & Tenders Portal |
|
Source description
Expected Outcome:Renewable heating can be directly used to efficiently decarbonise industrial processes. Concentrated solar thermal technologies offer a great potential to supply renewable heat for industry for temperatures between 150°C - 400°C. Nevertheless, efforts are still required to demonstrate these technologies for a variety of industrial processes.Proposals are expected to contribute to all the following outcomes:Showcase the capacity of concentrated solar thermal systems to largely meet the heat demand of industrial processes and to achieve a yearly solar fraction of at least 50%.Increase competitiveness of concentrated solar thermal for industrial applications. This is to be proven by an economically feasible business case; by reducing the Levelised Cost of Heating (LCoH); and by valorising and promoting the competitive advantages of the technology such as heat storage, flexi... |
||||||
| 40883 | Netherlands – Health and social work services – Hoogspecialistische Jeugdhulp ('HSJ') Buyer: Regionale Inkooporganisatie Groninger Gemeenten (RIGG) | Notice type: cn-social | Procedure: comp-dial | Contract: services... | Tender Procurement Contract | Netherlands | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Regionale Inkooporganisatie Groninger Gemeenten (RIGG) | Notice type: cn-social | Procedure: comp-dial | Contract: services | Deadline: 2027-03-31 |
||||||
| 40884 | Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Oxycodon/Naloxon (ATC-Code nach WHO: N02AA55) Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 |
||||||
| 40885 | Ireland – Painting work – Panel for the provision of Painting Services for WWETB Schools and Centre - 2. Buyer: Waterford and Wexford Education and Training Board_110494 | Notice type: cn-standard | Procedure: open | Contract: works |... | Tender Procurement Contract | Ireland | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Waterford and Wexford Education and Training Board_110494 | Notice type: cn-standard | Procedure: open | Contract: works | Deadline: 2027-03-31 |
||||||
| 40886 | Germany – Pharmaceutical products – Open-House-Rabattverträge 2025-02 Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 |
||||||
| 40887 | Germany – Pharmaceutical products – Open-House-Rabattverträge 2025-02 Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Techniker Krankenkasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 |
||||||
| 40888 | Germany – Medical practice services – AOK - Priomed Sekundärprävention nach § 140a SGB V Buyer: AOK - Die Gesundheitskasse in Hessen | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2027-03-... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK - Die Gesundheitskasse in Hessen | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2027-03-31 |
||||||
| 40889 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Tiotropiumbromid, Darreichungsform Inhalationslösung, ATC R03BB04 Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 |
||||||
| 40890 | Germany – Prefabricated buildings – Kompaktstationen bis 630 (1000) kVA und begehbare Stationen bis 1000 kVA jeweils mit Betonkörper Buyer: Thüga Aktiengesellschaft | Notice type: qu-sy | Contract: supplies | Deadline: 2027-03-31 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Thüga Aktiengesellschaft | Notice type: qu-sy | Contract: supplies | Deadline: 2027-03-31 |
||||||
| 40891 | Germany – Integrated circuit packages – Niederspannungsverteilungen in Ortsnetzstationen (NSV-ONS) Buyer: Thüga Aktiengesellschaft | Notice type: qu-sy | Contract: supplies | Deadline: 2027-03-31 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: Thüga Aktiengesellschaft | Notice type: qu-sy | Contract: supplies | Deadline: 2027-03-31 |
||||||
| 40892 | Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Mepolizumab (ATC: R03DX09) Buyer: AOK Sachsen - Anhalt | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Sachsen - Anhalt | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 |
||||||
| 40893 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Tetrabenazin, ATC N07XX06 Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 |
||||||
| 40894 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Zolmitriptan, ATC N02CC03 Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 |
||||||
| 40895 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Nitrendipin, ATC C08CA08 Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 |
||||||
| 40896 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Ranibizumab, als Durchstechflasche, ATC S01LA04 Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 |
||||||
| 40897 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Metronidazol Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 |
||||||
| 40898 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Colestyramin, ATC C10AC01 Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 |
||||||
| 40899 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Risperidon, als parenterale Depotform, ATC N05AX08 Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 |
||||||
| 40900 | Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Betamethason und Antibiotika, ATC D07CC01 Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Dea... | Tender Procurement Contract | Germany | Not provided on the source page. Please check the official source. | Open Mar 31, 2027 Open | TED / Tenders Electronic Daily |
|
Source description
Buyer: AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-03-31 |
||||||